Clinical trial Recruiting at 1 site Interventional Ages 16 to 22

Faster tooth movement using alveolar decortication plus concentrated growth factor (CGF) injection

Official title: Impact of Alveolar Decortication Combined With CGF Injection on Acceleration of Maxillary Canine Retraction-A Randomized Clinical Trial

Run by Tanta University · NCT06975358 · Data updated 2026-11-12

This study will try combining alveolar bone decortication with concentrated growth factor (CGF) injections to speed up canine retraction in 16–22-year-olds who need maxillary first premolar extractions.

Quick facts

Study typeInterventional
Ages16 Years to 22 Years
SexAll
Enrollment24 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Tanta)
StatusRecruiting
StartedMay 20, 2025
Main results expectedFebruary 1, 2027
Study endsMarch 1, 2027
Registry record updatedSeptember 29, 2026
Trial IDNCT06975358 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 16–22-year-olds who need extraction of the maxillary first premolars and canine retraction with maximum anchorage and who have good oral hygiene and healthy periodontium.

Probably not a fit

Patients who are medically compromised, have severe maxillary crowding, take chronic NSAIDs or other drugs that interfere with tooth movement, or who had prior orthodontic treatment are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares alveolar decortication combined with CGF injection versus standard canine retraction without surgical acceleration in patients requiring extraction of the maxillary first premolars. Eligible participants are 16–22 years old with malocclusions that require maxillary premolar extraction and maximum anchorage for canine retraction, and who have good oral hygiene and periodontal health. The procedure involves a surgical decortication of the alveolar bone on the maxillary segment plus local injection of concentrated growth factor, with clinical measurement of the rate of tooth movement over the orthodontic treatment period. Outcomes will focus on speed of canine retraction and related periodontal safety measures.

Why it matters

Potential benefit: If successful, the technique could shorten orthodontic treatment time by accelerating tooth movement.

How similar studies have gone: Previous clinical and preclinical work on decortication and on platelet-derived growth products has shown some promise for accelerating tooth movement, but evidence is still limited and not uniformly conclusive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age of the patients ranged from 16: 22 years old.
2. Malocclusion that requires extraction of the maxillary first premolar and canine retraction (e.g. class I bimaxillary dentoalveolar protrusion and class II div 1 malocclusion).
3. Maximum anchorage needed for the maxillary arch as a part of the orthodontic treatment plan.
4. Good oral hygiene and periodontal condition.

Exclusion Criteria:

1. Medically compromised patients.
2. Severe crowding in the maxillary arch.
3. Chronic intake of NSAIDs or any medication that interfere with OTM.
4. Previous orthodontic treatment.

Where it's running

  • Tanta University
    Tanta, Tanta, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.